Polypoidal choroidal vasculopathy: an angiographic discussion

Yannuzzi LA, Sorenson J, Spaide RF, Lipson B . Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990; 10 (1): 1–8.

Ahuja RM, Stanga PE, Vingerling JR, Reck AC, Bird AC . Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol 2000; 84 (5): 479–484.

Pauleikhoff D, Löffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002; 240 (7): 533–538.

Chuah CT, Chee C . Idiopathic polypoidal choroidal vasculopathy as a cause of a disciform macular scar. Clin Experiment Ophthalmol 2003; 31 (2): 163–165.

Yannuzzi LA, Freund KB, Goldbaum M, Scassellati-Sforzolini B, Guyer DR, Spaide RF et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000; 107 (4): 767–777.

Tan CS, Wong HT, Lim BA, Hee OK, Lim TH . Polypoidal choroidal vasculopathy causing massive suprachoroidal haemorrhage. Eye 2007; 21 (1): 132–133.

Scassellati-Sforzolini B, Mariotti C, Bryan R, Yannuzzi LA, Giuliani M, Giovannini A . Polypoidal choroidal vasculopathy in Italy. Retina 2001; 21 (2): 121–125.

Iwama D, Tsujikawa A, Sasahara M, Hirami Y, Tamura H, Yoshimura N . Polypoidal choroidal vasculopathy with drusen. Jpn J Ophthalmol 2008; 52 (2): 116–121.

Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I et al. Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 2002; 133 (5): 639–648.

Cackett P, Wong D, Yeo I . A classification system for polypoidal choroidal vasculopathy. Retina 2009; 29 (2): 187–191.

Uyama M, Matsubara T, Fukushima I, Matsunaga H, Iwashita K, Nagai Y et al. Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol 1999; 117 (8): 1035–1042.

Akman A, Akbatur H, Yilmaz G, Aydin P . Peripheral idiopathic polypoidal choroidal vasculopathy. Eye 2000; 14 ( Part 4): 680–681.

Stanga PE, Lim JI, Hamilton P . Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 2003; 110 (1): 15–21.

Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC, Spaide RF et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999; 117 (11): 1503–1510.

Kwok AK, Lai TY, Chan CW, Neoh EL, Lam DS . Polypoidal choroidal vasculopathy in Chinese patients. Br J Ophthalmol 2002; 86 (8): 892–897.

Ross RD, Gitter KA, Cohen G, Schomaker KS . Idiopathic polypoidal choroidal vasculopathy associated with retinal arterial macroaneurysm and hypertensive retinopathy. Retina 1996; 16 (2): 105–111.

Lip PL, Hope-Ross MW, Gibson JM . Idiopathic polypoidal choroidal vasculopathy: a disease with diverse clinical spectrum and systemic associations. Eye 2000; 14 (Part 5): 695–700.

Lafaut BA, Aisenbrey S, Van den Broecke C, Bartz-Schmidt KU, Heimann K . Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000; 20 (6): 650–654.

Terasaki H, Miyake Y, Suzuki T, Nakamura M, Nagasaka T . Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol 2002; 86 (3): 321–327.

Matsuoka M, Ogata N, Otsuji T, Nishimura T, Takahashi K, Matsumura M . Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol 2004; 88 (6): 809–815.

Nakajima M, Yuzawa M, Shimada H, Mori R . Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2004; 48 (3): 249–255.

Okubo A, Sameshima M, Uemura A, Kanda S, Ohba N . Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol 2002; 86 (10): 1093–1098.

Kuroiwa S, Tateiwa H, Hisatomi T, Ishibashi T, Yoshimura N . Pathological features of surgically excised polypoidal choroidal vasculopathy membranes. Clin Experiment Ophthalmol 2004; 32 (3): 297–302.

Nakashizuka H, Mitsumata M, Okisaka S, Shimada H, Kawamura A, Mori R et al. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008; 49 (11): 4729–4737.

Sasahara M, Tsujikawa A, Musashi K, Gotoh N, Otani A, Mandai M et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 2006; 142 (4): 601–607.

Sho K, Takahashi K, Yamada H, Wada M, Nagai Y, Otsuji T et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003; 121 (10): 1392–1396.

Honda S, Imai H, Yamashiro K, Kurimoto Y, Kanamori-Matsui N, Kagotani Y et al. Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo Prefecture, Japan. Ophthalmologica 2009; 223 (5): 333–338.

Imai H, Honda S, Nakanishi Y, Yamamoto H, Tsukahara Y, Negi A . Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy. Br J Ophthalmol 2006; 90 (12): 1524–1530.

Saito M, Iida T, Nagayama D . Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment. Br J Ophthalmol 2008; 92 (12): 1642–1647.

Yuzawa M, Mori R, Haruyama M . A study of laser photocoagulation for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2003; 47 (4): 379–384.

Vilaplana D, Castilla M, Poposki V . Laser photocoagulation in idiopathic polypoidal choroidal vasculopathy. Over one year follow-up. Arch Soc Esp Oftalmol 2005; 80 (10): 597–602.

Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA . Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995; 15 (2): 100–110.

Akaza E, Mori R, Yuzawa M . Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy. Retina 2008; 28 (5): 717–722.

Wakabayashi T, Gomi F, Sawa M, Tsujikawa M, Tano Y . Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy. Br J Ophthalmol 2008; 92 (7): 936–940.

Lee WK, Lee PY, Lee SK . Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence. Jpn J Ophthalmol 2008; 52 (2): 108–115.

Tateiwa H, Kuroiwa S, Gaun S, Arai J, Yoshimura N . Polypoidal choroidal vasculopathy with large vascular network. Graefes Arch Clin Exp Ophthalmol 2002; 240 (5): 354–361.

Iijima H, Imai M, Gohdo T, Tsukahara S . Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 1999; 127 (3): 301–305.

Ojima Y, Hangai M, Sakamoto A, Tsujikawa A, Otani A, Tamura H et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 2009; 29 (1): 52–59.

Yuzawa M, Mori R, Kawamura A . The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 2005; 89 (5): 602–607.

Costa RA, Navajas EV, Farah ME, Calucci D, Cardillo JA, Scott IU . Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm. Prog Retin Eye Res 2005; 24 (5): 560–586.

Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006; 141 (3): 456–462.

Song JH, Byeon SH, Lee SC, Koh HJ, Kwon OW . Short-term safety and efficacy of a single intravitreal bevacizumab injection for the management of polypoidal choroidal vasculopathy. Ophthalmologica 2009; 223 (2): 85–92.

Reche-Frutos J, Calvo-Gonzalez C, Donate-Lopez J, Garcia-Feijoo J, Leila M, Garcia-Sanchez J . Short-term anatomic effect of ranibizumab for polypoidal choroidal vasculopathy. Eur J Ophthalmol 2008; 18 (4): 645–648.

Lee SY, Kim JG, Joe SG, Chung H, Yoon YH . The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy. Korean J Ophthalmol 2008; 22 (2): 92–99.

Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Oshima Y, Kamei M et al. Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol 2008; 92 (1): 70–73.

Lai TY, Chan WM, Liu DT, Luk FO, Lam DS . Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Br J Ophthalmol 2008; 92 (5): 661–666.

Cho M, Barbazetto IA, Freund KB . Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol 2009; 148 (1): 70–78.e1.

Ladas ID, Rouvas AA, Moschos MM, Synodinos EE, Karagiannis DA, Koutsandrea CN . Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population. Eye 2004; 18 (5): 455–459.

Wen F, Chen C, Wu D, Li H . Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol 2004; 242 (8): 625–629.

Maruko I, Iida T, Saito M, Nagayama D, Saito K . Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007; 144 (1): 15–22.

Liu Y, Wen F, Huang S, Luo G, Yan H, Sun Z et al. Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 2007; 245 (10): 1441–1445.

Byeon SH, Lee SC, Oh HS, Kim SS, Koh HJ, Kwon OW . Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol 2008; 52 (1): 57–62.

Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y et al. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology 2004; 111 (8): 1576–1584.

Silva RM, Figueira J, Cachulo ML, Duarte L, Faria de Abreu JR, Cunha-Vaz JG . Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2005; 243 (10): 973–979.

Mauget-Faÿsse M, Quaranta-El Maftouhi M, De La Marnièrre E, Leys A . Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy. Eur J Ophthalmol 2006; 16 (5): 695–704.

Akaza E, Yuzawa M, Matsumoto Y, Kashiwakura S, Fujita K, Mori R . Role of photodynamic therapy in polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2007; 51 (4): 270–277.

Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA . Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Retina 2007; 27 (7): 825–831.

Otani A, Sasahara M, Yodoi Y, Aikawa H, Tamura H, Tsujikawa A et al. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2007; 144 (1): 7–14.

Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y et al. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2008; 115 (1): 141–146.

Kurashige Y, Otani A, Sasahara M, Yodoi Y, Tamura H, Tsujikawa A et al. Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2008; 146 (4): 513–519.